Community/Retail

Cozaar is indicated for the treatment of hypertension in adults and children over 6 years of age.

Nexium 24 HR offers relief of frequent heartburns.

Carlie Traylor, PharmD, discussed the Community Pharmacy Fellowship from the National Community Pharmacists Association and CPESN.

It is essential that women are informed of the risks of potentially teratogenic medications because most birth defects are likely to happen early in pregnancy before women become aware they are pregnant.

Pharmacists’ expertise in medication use has expanded their role to a critical member of the multi-disciplinary care team.

Individuals with multiple sclerosis should follow vaccine guidelines before starting disease-modifying therapies, case study results show.

Allibiotic CF is intended to help support healthy seasonal and year-round immune function.

Al Carter, MS, PharmD, RPh, discussed the Buying Medication Safely Campaign from the National Association of Boards of Pharmacy.

In recent years, the auditing process has evolved into a full-blown investigation, often requiring pharmacies to submit hundreds of pages of documentation

Michael Abrams, MPH, PhD, senior health researcher at Public Citizen’s Health Research Group, discusses whether classification of gabapentin as schedule V would end patients’ access to the drug.

In the third part of the series, we further explore the factors that contribute to overall happiness in a position.

Exenatide (Bydureon) is a GLP-1 receptor agonist indicated to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings.

Australian Dream is indicated for arthritis pain relief.

The commission “Time for United Action on Depression,” authored by 25 experts from 11 countries, seeks to unify global efforts among governments, health care providers, researchers, people living with depression, and their families to improve care and prevention, fill knowledge gaps, and increase awareness.

Headache disorders most affect the ability to do physical labor, decision-making skills, and memory, investigators from the University of Copenhagen say.

Exenatide (Byetta) is a GLP-1 receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus

Advil Sinus Congestion & Pain offers temporary relief of the symptoms associated with cold or flu, such as sinus pressure, headache, and fever.

The COVID-19 pandemic highlighted the importance of managing infections properly globally and the need for stewardship networks among partners.

Despite early excitement about the potential for pharmacists to prescribe COVID-19 oral antivirals, the program does not provide that ability.

The risk of death from CVD was approximately 15% lower for those with the highest vegetable intake compared to the lowest vegetable intake.

Investigators advise third short for patients with weakened immune system, especially organ transplant recipients.

Pharmacists must understand the value of monitoring changes in quality of life and headache frequency to help facilitate the decision to continue, discontinue, or restart migraine prophylaxis.

Ten quiz questions to assess your knowledge on common treatments for heart failure.

Basaglar is indicated to improve glycemic control in adults and children with type 1 diabetes and adults with type 2 diabetes.

Loratadine (Alavert) is indicated for runny nose, sneezing, itchy and watery eyes, sinus pressure, and nasal congestion.

Experts David Pope, PharmD, and Christina Madison, PharmD, FCCP, AAHIVP, discussed the Biden Administration's new test-to-treat plan.

Important evidence about the health effects of e-cigarettes can help shape public health best practices in the United States, the findings of an analysis suggest.

Empagliflozin and linagliptin (Glyxambi) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Amidst the frenzy of blockbuster medicines, the connection between the high price of a drug and how well it works is becoming looser.

The decision is informed by the results of a phase 2b proof-of-concept study that assessed the immunogenicity and safety of the drug in healthy pregnant women and their infants.